Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab. - Sato Y; Kodama T; Maesaka K; Kai M; Murai K; Tahata Y; Saito Y; Nakabori T; Ohkawa K; Tanaka S; Sakamori R; Miyazaki M; et al. (Journal for immunotherapy of cancer, 2026)